Open Access
Article
Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers
Catarina Castro Alves1,Fatima Carneiro1,Heinz Hoefler1,Karl-Friedrich Becker1
1
Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP) Rua Dr. Roberto Frias, S/N 4200-465 Porto, Portugal
DOI: 10.2741/3433 Volume 14 Issue 8, pp.3035-3050
Published: 01 January 2009
(This article belongs to the Special Issue Tumor microenvironment)
Abstract

Epithelial-mesenchymal-transition (EMT) is a crucial process during morphogenesis of multi-cellular organisms. EMT not only is a normal developmental process but also plays a role in tumor invasion and metastasis. Indeed, molecules involved in EMT, such as the transcription factor and E-cadherin repressor Slug (SNAI2), have recently been demonstrated to be important for cancer cells to down-regulate epithelial markers and up-regulate mesenchymal markers in order to become motile and invasive. Here we summarize major studies focusing on Slug expression in human tumor samples. We review a total of 13 studies involving 1150 cases from 9 different types of tumors. It is becoming clear that this transcription factor plays a role in the progression of some tumor types, including breast and gastric cancer. Interestingly, Slug expression is not always associated with down-regulation of E-cadherin. The mode of action, the signaling pathways involved in its regulation, and the interplay with other EMT regulators need to be addressed in future studies in order to fully understand Slug's role in tumor progression.

Share and Cite
Catarina Castro Alves, Fatima Carneiro, Heinz Hoefler, Karl-Friedrich Becker. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Frontiers in Bioscience-Landmark. 2009. 14(8); 3035-3050.